Daiwa Securities Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Buy |
104
+9
| +9% | +$1.21K | ﹤0.01% | 1108 |
|
|
2025
Q1 | $17K | Hold |
95
| – | – | ﹤0.01% | 1075 |
|
|
2024
Q4 | $15K | Sell |
95
-10
| -10% | -$1.58K | ﹤0.01% | 1096 |
|
|
2024
Q3 | $19K | Hold |
105
| – | – | ﹤0.01% | 1100 |
|
|
2024
Q2 | $19K | Hold |
105
| – | – | ﹤0.01% | 1128 |
|
|
2024
Q1 | $19K | Sell |
105
-10
| -9% | -$1.81K | ﹤0.01% | 1133 |
|
|
2023
Q4 | $14K | Buy |
115
+19
| +20% | +$2.31K | ﹤0.01% | 1142 |
|
|
2023
Q3 | $11K | Hold |
96
| – | – | ﹤0.01% | 1118 |
|
|
2023
Q2 | $11K | Hold |
96
| – | – | ﹤0.01% | 1128 |
|
|
2023
Q1 | $8K | Hold |
96
| – | – | ﹤0.01% | 1114 |
|
|
2022
Q4 | $8K | Hold |
96
| – | – | ﹤0.01% | 1119 |
|
|
2022
Q3 | $7K | Hold |
96
| – | – | ﹤0.01% | 1138 |
|
|
2022
Q2 | $6K | Buy |
96
+20
| +26% | +$1.25K | ﹤0.01% | 1150 |
|
|
2022
Q1 | $5K | Hold |
76
| – | – | ﹤0.01% | 1169 |
|
|
2021
Q4 | $5K | Hold |
76
| – | – | ﹤0.01% | 1190 |
|
|
2021
Q3 | $4K | Buy |
76
+33
| +77% | +$1.74K | ﹤0.01% | 1189 |
|
|
2021
Q2 | $3K | Hold |
43
| – | – | ﹤0.01% | 1105 |
|
|
2021
Q1 | $3K | Buy |
43
+6
| +16% | +$419 | ﹤0.01% | 1109 |
|
|
2020
Q4 | $2K | Buy |
+37
| New | +$2K | ﹤0.01% | 1123 |
|